Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search

Coumarins

Citations 1-10 of 41 total displayed.

Most recent content (8 May 2008):

Articles
The Genetic Architecture of Intracerebral Hemorrhage
Natalia S. Rost, Steven M. Greenberg, and Jonathan Rosand
Stroke published May 8, 2008, doi:10.1161/STROKEAHA.107.501650 [Abstract]  

Past content (since Oct 2001):

Original Contributions
Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk: The Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE-W)
Jeff S. Healey, Robert G. Hart, Janice Pogue, Marc A. Pfeffer, Stefan H. Hohnloser, Raffaele De Caterina, Greg Flaker, Salim Yusuf, and Stuart J. Connolly
Stroke 39: 1482 -1486; published online before print as doi:10.1161/STROKEAHA.107.500199 [Abstract] [Full text]  

Articles
Comparison of 12 Risk Stratification Schemes to Predict Stroke in Patients With Nonvalvular Atrial Fibrillation
Stroke Risk in Atrial Fibrillation Working Group
Stroke published April 17, 2008, doi:10.1161/STROKEAHA.107.501825 [Abstract]  

Cochrane Corner
Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No History of Stroke or Transient Ischemic Attacks
Maria I. Aguilar and Robert Hart
Stroke 39: 1399 -1400; published online before print as doi:10.1161/STROKEAHA.107.500363 [Full text]  

Articles
Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No History of Stroke or Transient Ischemic Attacks
Maria I. Aguilar and Robert Hart
Stroke published March 6, 2008, doi:10.1161/STROKEAHA.107.500363 [Abstract]  

Articles
Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk. The Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE-W)
Jeff S. Healey, Robert G. Hart, Janice Pogue, Marc A. Pfeffer, Stefan H. Hohnloser, Raffaele De Caterina, Greg Flaker, Salim Yusuf, and Stuart J. Connolly
Stroke published March 6, 2008, doi:10.1161/STROKEAHA.107.500199 [Abstract]  

Editorials
Predicting Stroke Risk in Patients With Atrial Fibrillation
Daniel G. Hackam
Stroke 38: 2409 ; published online before print as doi:10.1161/STROKEAHA.107.488114 [Full text]  

Original Contributions
Can Patients at Elevated Risk of Stroke Treated With Anticoagulants Be Further Risk Stratified?
Lawrence Baruch, Brian F. Gage, Jay Horrow, Steen Juul-Möller, Arthur Labovitz, Maria Persson, and Miguel Zabalgoitia
Stroke 38: 2459 -2463; published online before print as doi:10.1161/STROKEAHA.106.477133 [Abstract] [Full text]  

Articles
Predicting Stroke Risk in Patients With Atrial Fibrillation
Daniel G. Hackam
Stroke published August 2, 2007, doi:10.1161/STROKEAHA.107.488114 [Abstract]  

Articles
Can Patients at Elevated Risk of Stroke Treated With Anticoagulants Be Further Risk Stratified?
Lawrence Baruch, Brian F. Gage, Jay Horrow, Steen Juul-Möller, Arthur Labovitz, Maria Persson, and Miguel Zabalgoitia
Stroke published August 2, 2007, doi:10.1161/STROKEAHA.106.477133 [Abstract]  

[Next page]
Pages: 1 2 3 4 5

* Subspecialty Collections Home

* Show  Coumarins
 collections from other journals.

* Related collections:
 Anticoagulants
 Coumarins
 Heparin
 Other anticoagulants